Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 1/20 | 1.00 |
| ▸ | CA12 | O43570 | 6/20 | 0.82 |
| ▸ | CA2 | P00918 | 6/20 | 0.82 |
| ▸ | PKM | P14618 | 1/20 | 0.76 |
| ▸ | CA9 | Q16790 | 5/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.75 |
| ▸ | MPO | P05164 | 8/20 | 0.72 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.67 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2794849 | 0.90 | CA12 (1.00) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL31532322 | 0.90 | CA12 (1.00) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL12083246 | 0.90 | TSHR (0.82) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL6435315 | 0.89 | PKM (0.96) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL7930135 | 0.88 | TSHR (0.78) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL30586214 | 0.88 | CA12 (0.95) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL14354016 | 0.88 | CA12 (0.95) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL30586212 | 0.88 | CA12 (0.95) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL30197711 | 0.88 | CA12 (0.95) | TSHRCYP2D6HIF1ACA12CA2 | |
| SCHEMBL30586211 | 0.88 | CA12 (0.95) | TSHRCYP2D6HIF1ACA12CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115073309-A | Preparation method of o-hydroxybenzylamine | 苏州敬业医药化工有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-109223579-B | Dental restoration material and preparation method thereof | 张庆鹏 | 2021-04-13 | — | — | CN | claimed |
| EP-2797934-B1 | CATALYST COMPOSITIONS CONTAINING N,N-BIS[2-HYDROXIDEBENZYL]AMINE TRANSITION METAL COMPOUNDS FOR THE POLYMERIZATION OF OLEFINS | CHEVRON PHILLIPS CHEMICAL CO (US) | 2016-08-03 | — | — | EP | claimed |
| US-9115225-B2 | Catalyst systems for production of alpha olefin oligomers and polymers | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-08-25 | — | — | US | claimed |
| US-8987394-B2 | Catalyst compositions for the polymerization of olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2015-03-24 | — | — | US | claimed |
| EP-2797934-A1 | CATALYST COMPOSITIONS CONTAINING N, N-BIS [2-HYDROXIDEBENZYL]AMINE TRANSITION METAL COMPOUNDS FOR THE POLYMERIZATION OF OLEFINS | Chevron Phillips Chemical Company LP (US) | 2014-11-05 | — | — | EP | claimed |
| US-20140296456-A1 | Catalyst Systems for Production of Alpha Olefin Oligomers and Polymers | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2014-10-02 | — | — | US | claimed |
| US-20140296453-A1 | Catalyst Compositions for the Polymerization of Olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2014-10-02 | — | — | US | claimed |
| US-8791217-B2 | Catalyst systems for production of alpha olefin oligomers and polymers | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-07-29 | — | — | US | claimed |
| US-8785576-B2 | Catalyst compositions for the polymerization of olefins | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2014-07-22 | — | — | US | claimed |
| US-20130172497-A1 | CATALYST COMPOSITIONS FOR THE POLYMERIZATION OF OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | US | claimed |
| WO-2013101478-A1 | CATALYST SYSTEMS FOR PRODUCTION OF ALPHA OLEFIN OLIGOMERS AND POLYMERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | WO | claimed |
| US-20130172498-A1 | CATALYST SYSTEMS FOR PRODUCTION OF ALPHA OLEFIN OLIGOMERS AND POLYMERS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | US | claimed |
| WO-2013101476-A1 | CATALYST COMPOSITIONS CONTAINING N, N-BIS [2-HYDROXIDEBENZYL] AMINE TRANSITION METAL COMPOUNDS FOR THE POLYMERIZATION OF OLEFINS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-07-04 | — | — | WO | claimed |
| EP-2349995-A1 | SELECTIVE SEPRASE INHIBITORS | Molecular Insight Pharmaceuticals, Inc. (US) | 2011-08-03 | — | — | EP | claimed |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | MOLECULAR INSIGHT PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | claimed |
| WO-2010036814-A1 | SELECTIVE SEPRASE INHIBITORS | MOLECULAR INSIGHT PHARMACEUTICALS, INC. (US) | 2010-04-01 | — | — | WO | claimed |
| CN-109415468-B | Electro-optical polymers | 国立研究开发法人情报通信研究机构 | 2024-06-07 | — | — | CN | disclosed |
| WO-2001005741-A1 | METHOD FOR PRODUCING AMINES BY HOMOGENEOUSLY CATALYZED REDUCTIVE AMINATION OF CARBONYL COMPOUNDS | DEGUSSA AG (DE) | 2001-01-25 | — | — | WO | disclosed |
| US-4748276-A | Process for preparing N,N-bis(2-hydroxyethyl)benzylamine and N,N-bis(2-chloroethyl)benzylamine | STERLING DRUG INC. (US) | 1988-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172497-A1 | CATALYST COMPOSITIONS FOR THE POLYMERIZATION OF OLEFINS | AOC2, HMBS, NIT2 | TSHR 4868/4885CYP2D6 1110/4885HIF1A 3076/4885 |
| US-20100098633-A1 | SELECTIVE SEPRASE INHIBITORS | SLC6A7, DNPEP, PREP | TSHR 2864/4885CYP2D6 4523/4885HIF1A 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.